Acute leukaemia

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Kinase inhibitor 1 substance
Phase I/II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase I/II

1 trial
  • Incyte Corp. Commercial
    PONATINIB
    2023-509699-41-00 6 countries 2019 n=57 Orphan
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Incyte Corp. Commercial 1 Phase I/II 1
New trials by year
2019
1
← All indication landscapes